Procedure volume has barely changed since 2005. But surgeon fees are up 43%. The real growth story in breast augmentation is price, not volume — and the 2019 spike changed everything.
The procedure count in 2024 (306,196) is only 5% higher than 2005 (291,350). In 19 years, the market added roughly 15,000 annual procedures — barely keeping pace with population growth. But average surgeon fees went from $3,406 to $4,875 in the same period — a 43% increase, roughly triple the rate of volume growth.
Surgeon fees didn't rise gradually. They moved in three distinct phases — a flat decade, a slow climb, and a sudden spike that repriced the entire market overnight.
In a single year, average surgeon fees jumped from $3,824 to $4,789 — a 25.2% increase, the largest year-over-year price jump in the entire dataset. It fundamentally re-priced the market. Procedure volume actually dropped 9% that year, but total revenue hit an all-time high.
What converged to cause it: volume dropped 9% (fewer patients, higher per-case pricing), the BII conversation made consultations longer and more complex, the patient base shifted older and less price-sensitive, and implant manufacturer prices rose.
National expenditure (surgeon fees multiplied by procedure count) tells the true economic story. The market oscillated between $960M and $1.2B for a decade, then spiked to $1.37B in 2019 on falling volume, before COVID crashed it to $872M.
| Period | Avg Revenue | Volume | Price |
|---|---|---|---|
| 2005–2007 | $1.17B | Growing | Growing |
| 2008–2011 | $1.00B | Flat | Declining |
| 2012–2018 | $1.09B | Flat | Slowly growing |
| 2019 | $1.37B | Declining | Spiking |
| 2020 | $0.87B | Cratering | Flat |
Over the full 2005–2023 period, augmentation fee growth (43%) actually lagged cumulative CPI inflation (49%). The procedure is roughly the same price in real dollars. But the increases came in lurches — the 2015–2019 period saw real prices spike well above inflation.